Illumina tells EU judges it and Grail were ‘used as guinea pigs’ for new referral rules

Illumina told EU judges today that the European Commission had no right to seize jurisdiction over its acquisition of cancer-testing company Grail, and ran roughshod over its procedural rights. The acquisition...

Already a subscriber? Click here to view full article